Glassman Wealth Services’s OptimizeRx OPRX Stock Holding History

Glassman Wealth Services’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22	Closed	-$314	–	2044
2023 Q2	$314	Buy	+22	New	+$313	﹤0.01%	1732
2022 Q3	–	Sell	-7	Closed	–	–	1893
2022 Q2	$0	Buy	7 +3	+75%	+$89	﹤0.01%	1910
2022 Q1	$0	Buy	+4	New	+$177	﹤0.01%	1862

Other funds holding OPRX

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

Glassman Wealth Services's OPRX Position: Q3 2023 in Review

Glassman Wealth Services sold out of OptimizeRx (OPRX) in Q3 2023, closing a stake of 22 shares — an estimated $314 sold.

Glassman Wealth Services first reported a position in OPRX in Q1 2022 and held it in 3 quarters. The position peaked at $314 in Q2 2023. 94 funds tracked by Wall St. Rank hold OPRX as of Q3 2023.

Glassman Wealth Services reported no remaining OptimizeRx position as of Q3 2023 after selling out during the quarter.
Glassman Wealth Services sold 22 OptimizeRx shares in Q3 2023, an estimated $314.
Glassman Wealth Services first reported a position in OptimizeRx in Q1 2022 and held it in 3 quarters.
Glassman Wealth Services's OptimizeRx position peaked at $314 in Q2 2023.
94 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2023.

Based on Glassman Wealth Services's 13F filing for Q3 2023, filed 14 Nov 2023.